GILTERITINIB

Clinical trials for GILTERITINIB explained in plain language.

Never miss a new study

Get alerted when new GILTERITINIB trials appear

Sign up with your email to follow new studies for GILTERITINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Race to stop Cancer's return: two drugs face off in major blood cancer trial

Disease control Recruiting now

This study aims to find the best maintenance therapy to prevent cancer from returning in patients with a specific genetic type of acute myeloid leukemia (AML) who have received a stem cell transplant. Researchers will compare two drugs, gilteritinib and sorafenib, given for two y…

Matched conditions: GILTERITINIB

Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

GILTERITINIB

Get alerted when new GILTERITINIB trials appear

Race to stop Cancer's return: two drugs face off in major blood cancer trial